Skip to the content
halfrx
← LillyDirect

tirzepatide through LillyDirect

$299
a month all-in, once titrated
✓ verified 2026-09-13

Last updated 2026-09-13 — the price on this page. Read and dated by Alex Seot.

Can you get tirzepatide through LillyDirect, and what does it cost?

LillyDirect supplies tirzepatide as the branded, FDA-approved product. halfrx records $299 a month all-in once titrated, read from its own published page on 2026-09-13. That is the maintenance figure rather than an introductory rate, because the starting dose is not the dose anyone stays on. It is not the only route: halfrx records 5 verified ways to buy tirzepatide, and 3 of them are cheaper — the lowest at $249 a month. Nothing sits on LillyDirect's public record here: no FTC action, no state action, no failing BBB grade and no matched FDA warning letter.

What LillyDirect gets right, and what it does not

Each line is read from a cited source rather than from a reviewer's impression, and these are LillyDirect's own — nothing here is shared with the other sellers of this molecule.

  • +You buy from Eli Lilly itself. No telehealth membership, no cancellation policy to fight, no compounding pharmacy in the chain.
  • +Zepbound vials from $299/mo at the starter dose against a $1,086 list price — the largest manufacturer discount in the category.
  • +Foundayo (orforglipron) from $149 a month, the lowest self-pay price for a branded GLP-1 on this site, and a daily pill.
  • +Tirzepatide delivers the strongest average weight loss of any approved molecule.
  • −Lilly molecules only. If tirzepatide does not suit you, this channel has no semaglutide alternative.
  • −No clinical program, coaching or side-effect management — it is a pharmacy, not a weight service.
  • −Self-pay pricing is dose-scaled, so the $299 and $149 headlines are starter doses, not maintenance.
  • −Both products price maintenance doses on a 45-day refill condition, and Lilly counts a month as 28 days — so the advertised figure is a floor that assumes you never lapse.

What tirzepatide does, on the trial evidence

SURMOUNT-1, Study 1 on the label, 72 weeks: 20.9% mean weight loss at 15 mg against 3.1% on placebo, intention-to-treat. It is the trial behind Zepbound, the approved product built on this molecule.

FDA status of the approved product: FDA approved for chronic weight management and obstructive sleep apnea, since 2023-11-08.

List price of the approved product is $1,086 a month, against $299 here — a gap of $787 a month, or $9,444 a year, which is the whole reason this route exists.

Which products tirzepatide is sold as, and what each costs direct

ProductDirect priceMaintenance doseChecked
Zepbound$4495 mg, 10 mg or 15 mg once weekly2026-08-19
Mounjaro$4992.5 mg to 15 mg once weekly, set by blood sugar control2026-09-21

These products are priced differently direct, so LillyDirect's one figure, $299, does not stand for each of them.

What you are actually buying each month

Zepbound

One injection a week. The label reaches the maintenance dose in week 5, so the first 4 weeks are on a lower starting dose. An advertised starting price buys that dose, not the one you stay on, which is why the price above is the maintenance one.

WeeksDoseNote
1–42.5 mgInitiation only. The label says in as many words that 2.5 mg is not approved as a maintenance dose.
5–85 mgThe first dose that can be kept long term.
9–127.5 mgOptional. Increases come in 2.5 mg steps, no sooner than every 4 weeks.
13–1610 mgA maintenance dose, and the lowest one approved for sleep apnea.
17–2012.5 mgOptional.
21 and on15 mgMaximum. Reachable no earlier than week 21.

Maintenance: 5 mg, 10 mg or 15 mg once weekly. FDA prescribing information for Zepbound (tirzepatide)

Mounjaro

One injection a week.

WeeksDoseNote
1–42.5 mgStarting dose.
5 and on2.5 mg → 15 mgRaised in 2.5 mg steps, each held at least 4 weeks, only if glycemic control needs it. The August 2026 label dropped the fixed move to 5 mg at week 5 and the line that 2.5 mg is not a glycemic-control dose.

Maintenance: 2.5 mg to 15 mg once weekly, set by blood sugar control. FDA prescribing information for Mounjaro (tirzepatide, diabetes label)

Why LillyDirect rather than the cheapest route

Computed for this seller against every other verified route to the same molecule, so it is a different answer on every one of these pages.

Where it sits on price
4th of 5 verified routes, $50 a month above Noom Med at $249 — $600 over a year, which is the number the choice actually turns on.
What only this route gives
No other verified route here supplies the FDA-approved product. The cheaper figures are compounded copies, which is a different legal status rather than the same product for less.
What the money buys besides the drug
LillyDirect sells the medication only, filled against a prescription written elsewhere. There is no program around the drug to pay for.

Other verified routes to tirzepatide

The pages ranking for this question cover one seller. Cheapest first, each with the date it was read.

RouteA monthWhat it isChecked
Noom Med$249compounded, not FDA approved2026-09-22
Found$289compounded, not FDA approved2026-09-22
Henry Meds$297compounded, not FDA approved2026-09-20
Medvi$299provider2026-09-14

Everything on LillyDirect

This page exists only where LillyDirect actually supplies tirzepatide in the same form the medication is sold in — sharing a molecule is not the same as selling the product. Every figure carries its source and the date it was read.

Something on this page wrong? Tell us

Please leave out anything about your own health. How a report is handled: privacy.